Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab

Jostein Dahle(Oslo University Hospital), Roy H. Larsen(Norconsult (Norway)), Jørgen Borrebæk(Bayer (Norway)), Thora J. Jónasdóttir(Norwegian Veterinary Institute), Jahn M. Nesland(Oslo University Hospital), Helèn Heyerdahl(Nordic Nanovector (Norway)), Anne Kristine Hjelmerud(Oslo University Hospital)
European Journal of Nuclear Medicine and Molecular Imaging
July 10, 2009
10.1007/s00259-009-1197-7
Cited by 43

Related Papers

5-Aminolevulinic acid-based photodynamic therapy
|Cancer|1997|976
Correlation of Subcellular and Intratumoral Photosensitizer Localization with Ultrastructural Features After Photodynamic Therapy
|Ultrastructural Pathology|1996|214
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
|Photochemistry and Photobiology|1995|181
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
|PubMed|2000|118
Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma
|American Journal Of Pathology|1998|114